| 前收盘价格 | 0.195 |
| 收盘价格 | 0.195 |
| 成交量 | 305,074 |
| 平均成交量 (3个月) | 1,510,358 |
| 市值 | 126,708,600 |
| 价格/销量 (P/S) | 1.41 |
| 股市价格/股市净资产 (P/B) | 7.00 |
| 52周波幅 | |
| 利润日期 | 29 Aug 2025 - 2 Sep 2025 |
| 营业利益率 (TTM) | -6,048.54% |
| 稀释每股收益 (EPS TTM) | -0.020 |
| 季度收入增长率 (YOY) | 533.80% |
| 流动比率 (MRQ) | 9.00 |
| 营业现金流 (OCF TTM) | -5.21 M |
| 杠杆自由现金流 (LFCF TTM) | -3.07 M |
| 资产报酬率 (ROA TTM) | -35.77% |
| 股东权益报酬率 (ROE TTM) | -76.45% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (AU) | 混合的 | 混合的 |
| Health Information Services (全球的) | 看跌 | 混合的 | |
| 股票 | ECHOIQLTD FPO [EIQ] | - | - |
AIStockmoo 评分
1.6
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 4.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.63 |
|
Echo IQ Ltd is an Australian medical technology company focused on improving decision-making in cardiology. Its proprietary EchoSolv platform leverages AI-driven analysis of echocardiographic data to help clinicians detect Aortic Stenosis (AS) and other conditions with greater accuracy and efficiency. The company is focused on expanding its strategic partnerships, progressing regulatory pathways, and completing successful deployments of its technology in the USA healthcare market to establish its position in AI-enabled cardiovascular care. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 投资方式 | Small Growth |
| 内部持股比例 | 34.06% |
| 机构持股比例 | 0.22% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合